Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/05/19/2447129/0/en/Annual-General-Meeting-of-Active-Biotech-AB.html
https://www.globenewswire.com/news-release/2022/04/28/2430974/0/en/Annual-Report-2021-Active-Biotech-AB-publ.html
https://www.globenewswire.com/news-release/2022/04/26/2428706/0/en/Active-Biotech-strengthens-the-patent-protection-for-laquinimod-in-eye-disorders.html
https://www.globenewswire.com/news-release/2022/04/21/2426095/0/en/Active-Biotech-Interim-Report-Q1-2022.html
https://www.globenewswire.com/news-release/2022/04/20/2425657/0/en/Active-Biotech-NOTICE-OF-ANNUAL-GENERAL-MEETING-OF-SHAREHOLDERS.html
https://www.globenewswire.com/news-release/2022/03/31/2413465/0/en/Number-of-shares-and-votes-in-Active-Biotech.html
https://www.globenewswire.com/news-release/2022/03/25/2410371/0/en/Correction-Active-Biotech-Year-End-Report-2021.html
https://www.globenewswire.com/news-release/2022/02/09/2382305/0/en/Active-Biotech-Year-End-Report-2021.html
https://www.globenewswire.com/news-release/2022/02/07/2379644/0/en/Active-Biotech-announces-first-patient-dosed-in-the-combination-part-of-the-phase-Ib-IIa-study-of-tasquinimod-in-multiple-myeloma.html